ELDISINE

This brand name is authorized in Austria, France, Italy, UK.

Active ingredients

The drug ELDISINE contains one active pharmaceutical ingredient (API):

1	Vindesine UNII CPH2U7DNDY - VINDESINE SULFATE
	Vindesine is an antineoplastic agent derived from vinblastine, like the other vinca alkaloids it causes mitotic arrest in metaphase by binding to microtubular protein.
	Read more about Vindesine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ELDISINE Powder for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01CA03	Vindesine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CA Vinca alkaloids and analogues
Discover more medicines within L01CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	61886269
GB	Medicines & Healthcare Products Regulatory Agency	75011
IT	Agenzia del Farmaco	025289024